Form 4: Zymeworks Inc. Grants Stock Options to Neil Gallagher

Zymeworks Inc. has granted stock options to Neil Gallagher, exercisable at $13.06 per share, vesting after the next annual general meeting.

Summary

• Zymeworks Inc. granted Neil Gallagher stock options to purchase 31,000 shares of common stock.
• The exercise price for these options is $13.06 per share.
• The options vest on the date of the next annual general meeting following the grant date of December 10, 2024.
• The options expire on December 9, 2034.

Sentiment

Score: 7

Explanation: The document describes a routine stock option grant, which is generally positive for employee motivation and alignment with company goals. It is not a major event, but it is a positive indicator of employee compensation.

Positives

• The granting of stock options can serve as an incentive for Neil Gallagher.
• The vesting schedule aligns with the company's performance and shareholder interests.

Risks

• The value of the stock options is dependent on the future performance of Zymeworks Inc.'s stock price.
• There is a risk that the stock price may not reach the exercise price, rendering the options worthless.

Future Outlook

The stock options will vest after the next annual general meeting following the grant date, which is a future event.

Industry Context

Stock options are a common form of compensation in the biotechnology industry, used to attract and retain talent.

Comparison to Industry Standards

• Stock option grants are a standard practice in the biotech industry, often used to align employee interests with those of shareholders.
• The vesting schedule, tied to the annual general meeting, is a typical approach to ensure long-term commitment.
• The exercise price of $13.06 is specific to Zymeworks' stock performance and market conditions at the time of the grant.

Stakeholder Impact

• The stock option grant may positively impact employee morale and motivation.
• Shareholders may see this as a positive step in aligning employee interests with company performance.

Next Steps

• The stock options will vest after the next annual general meeting following the grant date.

Key Dates

Keywords

stock options, equity compensation, vesting, Neil Gallagher, Zymeworks Inc., common stock